Rocket Pharmaceuticals, Inc. Common Unit, Outstanding
Rocket Pharmaceuticals, Inc. (RCKT) had Common Unit, Outstanding of 26.93 million shares as of 2016-06-30, per its 10-Q filed 2016-08-10.
Discontinued › Balance Sheet › Equity › Limited Liability Company (LLC) Members' Equity
us-gaap:CommonUnitOutstanding · last filed 2016-08-10
- 2016-06-30: Common Unit, Outstanding 26.93M shares.
- 2016-03-31: Common Unit, Outstanding 26.42M shares.
- 2015-12-31: Common Unit, Outstanding 26.42M shares.
- 2015-09-30: Common Unit, Outstanding 26.41M shares.
| Period end | Common Unit, Outstanding |
|---|---|
| 2016-06-30 | 26.93M shares 10-Q · filed 2016-08-10 |
| 2016-03-31 | 26.42M shares 10-Q · filed 2016-05-11 |
| 2015-12-31 | 26.42M shares 10-Q · filed 2016-08-10 |
| 2015-09-30 | 26.41M shares 10-Q · filed 2015-11-12 |
| 2015-06-30 | 16.33M shares 10-Q · filed 2015-08-07 |
| 2015-03-31 | 16.33M shares 10-Q · filed 2015-05-14 |
| 2014-12-31 | 1.02M shares 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |